Pacira BioSciences (NASDAQ:PCRX) Price Target Raised to $32.00
Pacira BioSciences (NASDAQ:PCRX – Free Report) had its price target raised by Needham & Company LLC from $30.00 to $32.00 in a research note released on Friday,Benzinga reports. They currently have a buy rating on the stock. PCRX has been the subject of a number of other research reports. Royal Bank of Canada restated a […]
Pacira BioSciences (NASDAQ:PCRX – Free Report) had its price target raised by Needham & Company LLC from $30.00 to $32.00 in a research note released on Friday,Benzinga reports. They currently have a buy rating on the stock. PCRX has been the subject of a number of other research reports. Royal Bank of Canada restated a […]
